| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 10899500 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 135 journal articles in the PubMed database | Email to a friend | | |
| Gocial B, Keye WR, Fein SH, et al.
Subcutaneously administered Repronex in female patients undergoing in vitro fertilization is as effective and well tolerated as intramuscular menotropin treatment. Repronex SC, IVF Study Group. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Fertil Steril 2000 Jul; 74(1):73-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Nichols J, Knochenhauer E, Fein SH, et al.
Subcutaneously administered Repronex in oligoovulatory female patients undergoing ovulation induction is as effective and well tolerated as intramuscular human menopausal gonadotropin treatment. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Fertil Steril 2001 Jul; 76(1):58-66.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Dickey RP, Thornton M, Nichols J, et al.
Comparison of the efficacy and safety of a highly purified human follicle-stimulating hormone (Bravelle) and recombinant follitropin-beta for in vitro fertilization: a prospective, randomized study. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Fertil Steril 2002 Jun; 77(6):1202-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Keye WR, Marrs RP, Check JH, et al.
Evaluation of mixed protocols with Bravelle (human-derived FSH) and Repronex (hMG) to assess clinical efficacy (EMBRACE) in women undergoing in vitro fertilization. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Fertil Steril 2004 Aug; 82(2):348-57.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Keye WR, Webster B, Dickey R, et al.
Subcutaneously administered Menopur, a new highly purified human menopausal gonadotropin, causes significantly fewer injection site reactions than Repronex in subjects undergoing in vitro fertilization. [Journal Article]
Reprod Biol Endocrinol 2005 Nov 9.:62.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Elkind-Hirsch KE, Bello S, Esparcia L, et al.
Serum human chorionic gonadotropin levels are correlated with body mass index rather than route of administration in women undergoing in vitro fertilization--embryo transfer using human menopausal gonadotropin and intracytoplasmic sperm injection. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Fertil Steril 2001 Apr; 75(4):700-4.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Dickey RP, Nichols JE, Steinkampf MP, et al.
Highly purified human-derived follicle-stimulating hormone (Bravelle) has equivalent efficacy to follitropin-beta (Follistim) in infertile women undergoing in vitro fertilization. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Reprod Biol Endocrinol 2003 Oct 3.:63.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Westergaard LG, Erb K, Laursen SB, et al.
Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a prospective randomized study. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Fertil Steril 2001 Sep; 76(3):543-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Hsieh Y, Tsai H, Chang C, et al.
Comparison of a single half-dose, long-acting form of gonadotropin-releasing hormone analog (GnRH-a) and a short-acting form of GnRH-a for pituitary suppression in a controlled ovarian hyperstimulation program. [Clinical Trial, Journal Article]
Fertil Steril 2000 Apr; 73(4):817-20.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
